Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inhibikase Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Revenues  0.10.10.10.00.00.00.00.3
            Revenue growth  1676.7%40.2%3169.9%-97.8%-99.5%-96.7%-98.9%771.7%
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.10.10.10.00.00.00.00.3
            Gross margin  100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]1.81.91.31.51.71.71.71.6
Research and development  4.52.93.13.03.03.03.43.2
EBITDA   [+]-6.0-4.7-4.3-4.5    
            EBITDA margin  -5191.3%-7299.8%-6822.3%-61876.5%-70817.1%-10081.5%-259334.4%-1361.2%
Depreciation and amortization  0.20.00.00.0    
EBIT   [+]-6.2-4.7-4.3-4.5-4.6-4.6-5.0-4.5
            EBIT margin  -5328.1%-7307.6%-6819.6%-61899.6%-70817.1%-10081.5%-259334.4%-1361.2%
Interest income, net   [+]0.40.20.10.0 0.00.00.0
Other income (expense), net    0.0     
Pre-tax income  -5.8-4.5-4.3-4.5-4.6-4.6-5.0-4.5
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -5.8-4.5-4.3-4.5-4.6-4.6-5.0-4.5
            Net margin  -4963.5%-6940.0%-6731.7%-61645.4%-70817.1%-10081.5%-259342.5%-1361.3%
   
Basic EPS   [+]($1.11)($0.16)($0.17)($0.18)($1.10)($0.18)($0.28)($0.18)
Diluted EPS   [+]($1.11)($0.16)($0.17)($0.18)($1.10)($0.18)($0.28)($0.18)
   
Shares outstanding (basic)   [+]5.227.525.225.24.225.218.225.1
Shares outstanding (diluted)   [+]5.227.525.225.24.225.218.225.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy